Growth Metrics

AtriCure (ATRC) Interest & Investment Income (2016 - 2025)

AtriCure (ATRC) has disclosed Interest & Investment Income for 16 consecutive years, with $1.3 million as the latest value for Q4 2025.

  • On a quarterly basis, Interest & Investment Income rose 10.55% to $1.3 million in Q4 2025 year-over-year; TTM through Dec 2025 was $4.5 million, a 1.01% increase, with the full-year FY2025 number at $4.5 million, up 1.01% from a year prior.
  • Interest & Investment Income was $1.3 million for Q4 2025 at AtriCure, up from $1.2 million in the prior quarter.
  • In the past five years, Interest & Investment Income ranged from a high of $1.4 million in Q4 2022 to a low of $76000.0 in Q2 2022.
  • A 5-year average of $758250.0 and a median of $946500.0 in 2024 define the central range for Interest & Investment Income.
  • Peak YoY movement for Interest & Investment Income: plummeted 66.91% in 2021, then surged 1178.57% in 2022.
  • AtriCure's Interest & Investment Income stood at $112000.0 in 2021, then soared by 1178.57% to $1.4 million in 2022, then fell by 27.3% to $1.0 million in 2023, then grew by 15.66% to $1.2 million in 2024, then rose by 10.55% to $1.3 million in 2025.
  • Per Business Quant, the three most recent readings for ATRC's Interest & Investment Income are $1.3 million (Q4 2025), $1.2 million (Q3 2025), and $941000.0 (Q2 2025).